. 2015 Apr 10;15:348. doi: 10.1186/s12889-015-1680-y

Table 3.

Diagnostic tests that will be performed in the study

Facility where the tests will be performed	Tests that will be performed
Laboratory at RU in Rwanda	» Urine analysis for pregnancy using QuickVue hCG (Quidel);
	» HIV testing followed RU SOPs, which are based on the Rwandan national guidelines, using DetermineTM
	HIV1/2 (Abbott Diagnostic Division, Hoofddorp, The Netherlands) as first test and Uni-Gold HIV (Trinity, Berkeley Heights, New Jersey, USA) as second test when the first test is reactive;
	» Wet mount microscopy;
	» HSV-2 (HerpeSelect 2 ELISA (Kalon Diagnostics) and syphilis testing assessed with RPR (Spinreact Reactivos, Girona, Spain), followed by TPHA (Spinreact Reactivos, Girona, Spain)
Laboratoire National de Référence, Kigali	» CT/NG molecular testing using the Presto CT/NG kit of Goffin Molecular Technologies, The Netherlands;
Laboratoire National de Référence, Kigali	» Elisa for HIV (VIRONOSTIKA HIV Uni-Form II Ag/Ab, bioMérieux Marcy l'Etoile, Marcy l'Etoile, France) if the first 2 tests done at the laboratory of RU showed discordant results.